Vivos Therapeutics, Inc.

VVOS ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-3 Feb 11, 2025
424B1 Jan 31, 2025
EFFECT Jan 30, 2025
CORRESP Jan 29, 2025
S-1/A Jan 29, 2025
UPLOAD Jan 23, 2025
S-1 Jan 22, 2025
SCHEDULE 13G Dec 30, 2024
424B5 Dec 26, 2024
8-K Dec 23, 2024
SCHEDULE 13G Dec 20, 2024
8-K Nov 27, 2024
4 Nov 27, 2024
4 Nov 27, 2024
SC 13G/A Nov 14, 2024
8-K Nov 14, 2024
10-Q Nov 14, 2024
SC 13G/A Nov 14, 2024 SC 13G/A
DEFA14A Nov 6, 2024
DEF 14A Oct 7, 2024
SC 13G Sep 24, 2024 SC 13G
8-K Sep 20, 2024
424B5 Sep 20, 2024
8-K Sep 18, 2024
8-K Sep 17, 2024
← Newer Page 4 of 12 · 287 filings Older →